WHO ICTRP trial
PHASE III Study to evaluate safety and efficacy OF Oral CP-690,550 AS AN…
CTRI/2013/01/003328 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2013/01/003328 |
|---|---|
| Public title | PHASE III Study to evaluate safety and efficacy OF Oral CP-690,550 AS AN INDUCTION THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS |
| Scientific title | A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF ORAL CP-690,550 AS AN INDUCTION THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS - NA |
| Primary sponsor | Pfizer Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | Czech Republic;Australia;Austria;Belgium;Brazil;Canada;Colombia;Croatia;Denmark;Estonia;France;Germany;Hungary;India;Israel;Italy;Latvia;Netherlands;New Zealand;Poland;Republic of… |
| Conditions | Health Condition 1: null- Ulcerative Colitis |
| Interventions | Intervention1: Experimental: 10mg BID: Drug: CP-690,550 oral tablets twice daily Duration: 9 weeks Intervention2: Experimental: 15mg BID: Drug: CP-690,550 oral tablets twice daily Duration: 9 weeks Control Intervention1: Placebo Comparator… |
| Registration date | Jan 28, 2013 |
| Target size | 545 |
| Secondary IDs | A3921095 Protocol version 30 Sep 2011;NCT01458951 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: